Biosimilar in lymphoma treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Autor principal: | Tanisha, Mehrin Haque |
---|---|
Altres autors: | Kabir, Eva Rahman |
Format: | Thesis |
Idioma: | English |
Publicat: |
Brac University
2021
|
Matèries: | |
Accés en línia: | http://hdl.handle.net/10361/15533 |
Ítems similars
-
CAR-T cell Therapy in B-cell Lymphoma
per: Faruk, Asef
Publicat: (2020) -
Targeted therapeutic options in the treatment of Breast Cancer
per: Alam, Kazi Tasnuva
Publicat: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
per: Tania, Umme
Publicat: (2023) -
Biologics and Biosimilars as Treatment Options for Psoriasis
per: Moya, Amena Khatun
Publicat: (2023) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
per: Tania, Umme
Publicat: (2021)